Dr. Robert L. Nussbaum

Parkinson Canada is pleased to announce that the 12th Donald Calne Lecture will be presented by Dr. Robert L. Nussbaum on Tuesday, May 31, at 7 p.m. in conjunction with the Canadian Association for Neuroscience annual conference being held in Toronto. His presentation will be about genetics and Parkinson’s and will be suitable for both the public and the scientific community.

Dr. Nussbaum received his training in medicine in the Harvard-MIT Joint Program in Health Technology, his internal medicine training at Barnes Hospital/Washington University, and his genetics training at Baylor College of Medicine. He is board certified in internal medicine, clinical genetics and clinical molecular genetics.
Dr. Nussbaum directed the original research that led to the discovery of mutations in alpha-synuclein in hereditary Parkinson disease in the mid-1990s and has been studying its role in Parkinson disease ever since. Dr. Nussbaum is currently the Chief Medical Officer for Invitae, a genetic testing and information company, based in San Francisco, U.S.A.

Be sure to save the date. Advance registration will be required as space is limited. More details will be posted on www.parkinson.ca as they become available, including how to register. The presentation is co-sponsored by Abbvie Canada.

About the Donald Calne Lecture

Finding better ways to detect, diagnose, treat and ultimately, cure Parkinson’s requires cooperation from a global scientific community. The Donald Calne Lectureship, established in Canada in 2002, honours research that makes an impact on the world stage. Each year, the award celebrates a distinguished neuroscientist whose research is helping us learn more about how to understand, diagnose, and treat Parkinson’s. The recipient gives a speech, on the state of Parkinson’s research, to Canadian scientists, medical professionals, people with Parkinson’s and their families. To learn more about this event and past recipients, visit www.parkinson.ca.